Acute myeloid leukemia (AML) Treatment in India

What is Acute Myeloid Leukemia (AML)?

AML stands for Acute Myeloid Leukemia, a blood cancer that begins in the blood and the source of the blood, bone marrow, which deals with myeloid cells responsible for the generation of red blood cells, white blood cells, and platelets. With acute myeloid leukaemia, the bone marrow produces abnormal myeloblasts, immature white blood cells that do not mature properly, thus crowding normal cells. Therefore, a variety of symptoms and complications arise.

What is the Importance of Timely Treatment?

• Preventing the Disease Progression: AML is an aggressive cancer that can quickly progress if active treatment is not initiated, often leading to severe complications, organ dysfunctions, and even death. However, passive management helps slow down the progression of the disease and thus increases the chances of survival.
• Encourage Treatment Response: AML's response to any treatment is always better when therapy is given early. The earlier the therapy is initiated, the higher the chance of inducing remission and preventing relapse; failure to treat in time translates into poorer prognoses and decreased effectiveness of treatment.
• Complications are obviated: Complications arise in AML due to the destruction of blood cells when the cells in the bone marrow get wiped out. Such complications include infections, bleeding, and anemia. After treating AML at its earliest possible stage, resolving the issues of these complications is much more favorable, with an increased chance of avoiding any complications that can be life-threatening.
• Good long-term prognosis: If treatment is started earlier, there is a better chance of long-term survival. Although AML remains hard to cure, if treatment is given aggressively after an early diagnosis, remission can be achieved. The patient diagnosed early stands a greater chance of favorable response to chemotherapy and stem cell transplant regimens.
• Quality of life: Early start of management can help in controlling a patient's symptoms like fatigue, pain, and infections, actually benefiting his quality of life during treatment. A delay can cause aggravation of these symptoms and disturb his daily living activities.

What are the Common Symptoms of Acute Myeloid Leukemia (AML)?

• Fatigue and Weakness
• Pale Skin
• Frequent Infections or Fever
• Easy Bruising or Bleeding
• Swollen Lymph Nodes
• Bone or Joint Pain
• Loss of Appetite or Unexplained Weight Loss
• Shortness of Breath or Dizziness
• Abdominal Pain or Fullness

Causes and Risk Factors of Acute Myeloid Leukemia (AML)

Causes

• Genetic Mutations
• Chromosomal Abnormalities
• Infections
• Immune System Disorders
• Exposure to Radiation or Chemicals

Risk Factors:

• Age
• Gender
• Family History
• Previous Cancer Treatment
• Environmental Exposures
• Genetic Syndromes

Latest Research and Technologies in the Treatment of Acute Myeloid Leukemia (AML) in India

The medical treatment of carcinoid tumours in India has adopted the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.

• Targeted Therapies: Novel drugs developed by targeting genetic mutations have improved treatment outcomes for AML patients, especially in the most severe cases.
• Immunotherapy: Immune checkpoint inhibitors such as CAR-T cell therapy that have not been previously applied will be harnessed in clinical trials in India as an arm towards developing new chemotherapy treatment for unimproved AML patients.
• Stem Cell Transplantation: There has been progress in HLA matching, graft-versus-host clinical outcome, and immune suppressive therapy, which contributed to successful rates of stem cell transplantation in this region, hence improving outcomes of high-risk or relapsed AML patients in India.
• Personalised Medicine and Diagnostics: Next-generation sequencing (NGS) and liquid biopsy would make it more personalised for treatment in identifying genetic mutations for relapse and precisely monitoring treatment response.
• Integration of Clinical Trials with AI: India is a part of international clinical trials primarily conducted for the best available therapies. Artificially intelligent and data analytic systems optimise treatment regimens and predict patients' disease outcomes for more personalised care for AML patients.

Acute Myeloid Leukemia (AML) Prevention Tip:

• Avoiding exposure to harmful chemicals: Reducing exposure to toxic substances such as benzene (produced by petrochemical industries) and cigarette smoke may reduce the likelihood of developing AML. Provide protective equipment in high-risk workplaces so that exposure is reduced.
• Limiting Exposure to Radiation: There are exposures which cannot be avoided, such as treatment with radiation from a pre-existing cancer diagnosis. Again, unnecessary exposure to X-rays and CT scans should be kept at a minimum as this may cause genetic mutations that might lead to leukemia in the future.
• Healthy Lifestyle Choices: Adopting healthy meal plans, exercising, and not smoking will significantly reduce the risk of developing AML. A strong immune system is crucial in fighting infections and diseases, including leukemia.
• Genetic Counseling Services for High-Risk Individuals: Genetic counseling is an option to consider if there is a family history of leukemia or inherited conditions like Down syndrome, Fanconi anemia, or Bloom syndrome. If there is, screening and early detection can solve the issues.
• Regular Health Check-Ups: These regular health check-ups will lead to early diagnosis of blood disorders. Early diagnosis of diseases such as myelodysplastic syndromes (MDS) will ensure early treatment and reduce the chances of developing AML.